Acceleron Pharma reported $696.61M in Current Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acceleron Pharma XLRN:US $ 696.61M 21.16M
Akebia Therapeutics AKBA:US $ 330.08M 0.99M
Alexion Pharmaceuticals ALXN:US $ 6452.6M 619.6M
Amgen AMGN:US $ 24380M 5281M
Arena Pharmaceuticals ARNA:US $ 790.92M 199.52M
Bayer BAYN:GR 31.94B 506M
Biomarin Pharmaceutical BMRN:US $ 2311.57M 46.27M
Bluebird Bio BLUE:US $ 832.32M 71.2M
Clovis Oncology CLVS:US $ 230.67M 65.69M
Dicerna Pharmaceuticals DRNA:US $ 589M 27.49M
Eli Lilly And LLY:US $ 17808.3M 512.8M
Exelixis EXEL:US $ 1662.03M 68.78M
Gilead Sciences GILD:US $ 14200M 275M
GlaxoSmithKline GSK:LN 18.25B 688M
Karyopharm Therapeutics KPTI:US $ 241.58M 31.92M
Mirati Therapeutics MRTX:US $ 1171.89M 106.2M
Neurocrine Biosciences NBIX:US $ 1005.7M 104.4M
Novartis NOVN:VX 26.25B 2.45B
Ptc Therapeutics PTCT:US $ 1011.14M 55.09M
Puma Biotechnology PBYI:US $ 136.92M 30.83M
Regeneron Pharmaceuticals REGN:US $ 13775.4M 437.8M
Rigel Pharmaceuticals RIGL:US $ 171.1M 13.09M
Sangamo Biosciences SGMO:US $ 447.4M 106.67M
Ultragenyx Pharmaceutical RARE:US $ 846.88M 102.61M
United Therapeutics UTHR:US $ 2385.9M 68M
Vertex Pharmaceuticals VRTX:US $ 8852.54M 395.03M